{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:52Z","timestamp":1789763932734,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ekir.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:40:50Z","timestamp":1607002850000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD"],"prefix":"10.1016","volume":"6","author":[{"given":"Guillermo Navarro","family":"Blackaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Ch\u00e1vez-I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa Edith","family":"Carre\u00f3n-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Gonz\u00e1lez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Villareal-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Roberto","family":"Barrientos Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Maggiani","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Romo","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torres Mayorga","family":"Jos\u00e9 Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Alberto","family":"G\u00f3mez Fregoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Isaac","family":"Michel Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.10.016_bib1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.10.016_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfy407","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA","volume":"34","author":"Sarafidis","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.016_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.arcmed.2013.10.007","article-title":"Identifying undetected cases of chronic kidney disease in Mexico. Targeting high risk populations","volume":"44","author":"Garc\u00eda-Garc\u00eda","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ekir.2020.10.016_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ekir.2018.07.018","article-title":"The tragedy of having ESRD in Mexico","volume":"3","author":"Garcia-Garcia","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.10.016_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MED.0000000000000275","article-title":"The interaction between thyroid and kidney disease: an overview of the evidence","volume":"23","author":"Rhee","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ekir.2020.10.016_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfu303","article-title":"The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease","volume":"30","author":"Rhee","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.016_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygcen.2008.12.008","article-title":"Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review","volume":"160","author":"van Hoek","year":"2009","journal-title":"Gen Compar Endocrinol"},{"key":"10.1016\/j.ekir.2020.10.016_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1681\/ASN.2010070766","article-title":"The renal manifestations of thyroid disease","volume":"23","author":"Mariani","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.016_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-08-0837","article-title":"Thyroid dysfunction and kidney disease","volume":"160","author":"Iglesias","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ekir.2020.10.016_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ije\/dyu126","article-title":"Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study","volume":"43","author":"Zhang","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ekir.2020.10.016_bib11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2215\/CJN.00800208","article-title":"Prevalence of subclinical hypothyroidism in patients with chronic kidney disease","volume":"3","author":"Chonchol","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.016_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/520281","article-title":"Thyroid disorders and chronic kidney disease","volume":"2014","author":"Mohamedali","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.016_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2265.2005.02236.x","article-title":"Correlation between severity of thyroid dysfunction and renal function","volume":"62","author":"den Hollander","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ekir.2020.10.016_bib14","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/s41598-018-19693-4","article-title":"Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2020.10.016_bib15","doi-asserted-by":"crossref","first-page":"41302","DOI":"10.1038\/srep41302","article-title":"Albuminuria is an independent risk factor of T4 elevation in chronic kidney disease","volume":"7","author":"Du","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1016\/j.ekir.2020.10.016_bib16","first-page":"483","article-title":"Thyroid function in patients with proteinuria","volume":"66","author":"Gilles","year":"2008","journal-title":"Netherlands J Med"},{"key":"10.1016\/j.ekir.2020.10.016_bib17","first-page":"378","article-title":"Deterioro de la funci\u00f3n renal asociado con hipotiroidismo","volume":"30","author":"Merino","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.ekir.2020.10.016_bib18","first-page":"15","article-title":"Subclinical hypothyroidism and the risk of chronic kidney disease in T2D subjects: a case-control and dose-response analysis","volume":"96","author":"Zhou","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.ekir.2020.10.016_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mayocp.2018.01.024","article-title":"Thyroid and death risk in US veterans with chronic kidney disease","volume":"93","author":"Rhee","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ekir.2020.10.016_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/ndt\/gfu024","article-title":"Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients","volume":"30","author":"Rhee","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.016_bib21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.ajkd.2013.10.009","article-title":"Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients","volume":"63","author":"Drechsler","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.016_bib22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2014-4311","article-title":"Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients","volume":"100","author":"Rhee","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.016_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2016-3616","article-title":"Thyroid status and mortality in a prospective hemodialysis cohort","volume":"102","author":"Rhee","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.016_bib24","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/jc.2016-1691","article-title":"Thyroid functional disease and mortality in a national peritoneal dialysis cohort","volume":"101","author":"Rhee","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.016_bib25","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ekir.2020.10.016_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000438750","article-title":"The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism","volume":"4","author":"Biondi","year":"2015","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ekir.2020.10.016_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.11622\/smedj.2016165","article-title":"The debate on treating subclinical hypothyroidism","volume":"57","author":"Loon","year":"2016","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ekir.2020.10.016_bib28","first-page":"26","article-title":"Subclinical hypothyroidism","volume":"376","author":"Peeter","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.10.016_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/2042018815616543","article-title":"Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits","volume":"7","author":"Javed","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.016_bib30","article-title":"Thyroid hormone replacement for subclinical hypothyroidism (Review)","volume":"3","author":"Villar","year":"2007","journal-title":"Cochrane Library"},{"key":"10.1016\/j.ekir.2020.10.016_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1470320312439140","article-title":"Cardiorenal disease development under chronic renin-angiotensin-aldosterone system suppression","volume":"13","author":"Sarafidis","year":"2012","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ekir.2020.10.016_bib32","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.016_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000101958","article-title":"Proteinuria as a therapeutic target in patients with chronic kidney disease","volume":"27","author":"Palmer","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.016_bib34","first-page":"S1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2020.10.016_bib35","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.016_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.ajkd.2012.07.011","article-title":"Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial","volume":"61","author":"Fernandez Juarez","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.016_bib37","first-page":"145","article-title":"Efectos a largo plazo de la espironolactona sobre la proteinuria y la funci\u00f3n renal en pacientes con enfermedad renal cr\u00f3nica","volume":"2","author":"Bianchi","year":"2007","journal-title":"Kidney Int. (Edici\u00f3n espa\u00f1ol)"},{"key":"10.1016\/j.ekir.2020.10.016_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1464-5491.2004.01194.x","article-title":"The effects of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study","volume":"21","author":"Rachmani","year":"2004","journal-title":"Diabetes Med"},{"key":"10.1016\/j.ekir.2020.10.016_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2020.10.016_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.ajkd.2005.03.007","article-title":"Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study","volume":"46","author":"Bianchi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.016_bib41","first-page":"17","article-title":"Papel de las estatinas en la enfermedad renal cr\u00f3nica","volume":"22","author":"Goicoechea","year":"2010","journal-title":"Clin Invest Arterioscl"},{"key":"10.1016\/j.ekir.2020.10.016_bib42","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/j.ajkd.2016.01.016","article-title":"Effect of statins on kidney disease outcomes: a systematic review and meta-analysis","volume":"67","author":"Su","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.016_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.016_bib44","first-page":"716","article-title":"Vitamina D y proteinuria: revisi\u00f3n cr\u00edtica de las bases moleculares y de la experiencia cl\u00ednica","volume":"33","author":"P\u00e9rez-G\u00f3mez","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.ekir.2020.10.016_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2020.10.016_bib46","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2020.10.016_bib47","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00090.2011","article-title":"Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy","volume":"302","author":"S\u00e1nchez-Ni\u00f1o","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ekir.2020.10.016_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.016_bib49","first-page":"115","article-title":"Study on renal function in patients with subclinical hypothyroidism. Response to treatment with levothyroxine","volume":"49","author":"Barovero","year":"2012","journal-title":"Rev Argent Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.016_bib50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-016-1081-8","article-title":"Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation","volume":"14","author":"Huang","year":"2016","journal-title":"Transl Med"},{"key":"10.1016\/j.ekir.2020.10.016_bib51","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/thy.2012.0475","article-title":"Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism","volume":"23","author":"Shin","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ekir.2020.10.016_bib52","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000507290","article-title":"Relationship between thyroid and kidney function: analysis from the Korea National Health and Nutrition Examination Survey between 2013 and 2015","volume":"45","author":"Kim","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ekir.2020.10.016_bib53","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2020.10.016_bib54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.ekir.2020.10.016_bib55","first-page":"1","article-title":"Hiperuricemia, gota y enfermedad renal","volume":"32","author":"Goicoechea","year":"2012","journal-title":"Nefrologia"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920316867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024920316867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:35:31Z","timestamp":1762832131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024920316867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2468024920316867"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.10.016","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}